Nootropic / Cognitive
Cerebrolysin
Also known as: FPF-1070
Cerebrolysin is not a single peptide but a complex biologic produced by enzymatic hydrolysis of purified porcine brain tissue, containing low-molecular-weight peptides (<10 kDa) and free amino acids. Manufactured by EVER Pharma (Austria), it is registered in 50+ countries (Europe, Asia, Russia, Latin America) for ischemic stroke, traumatic brain injury, and dementia, but is NOT FDA-approved in the United States.
Vendors carrying Cerebrolysin
0 listings, ranked by trust score
Each row is a (vendor, peptide) pair. Click through for the listing detail, the vendor's full trust profile, and any COAs they've published.
No vendors carrying this peptide are indexed yet.
Independent evidence
No COAs on file for Cerebrolysin
No third-party tests indexed yet. Phase 2 will surface more vendor evidence as the dataset grows.